Splanchnic haemodynamics in non-alcoholic fatty liver disease: Effect of a dietary/pharmacological treatment. A pilot study

Digestive and Liver Disease

Volumn 36, Issue 6, 2004, Pages 406-411

  Magalotti, D ^a   Marchesini, G ^a   Ramilli, S ^a   Berzigotti, A ^a   Bianchi, G ^a   Zoli, Marco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Echo Doppler; Metformin; Non alcoholic fatty liver disease; Splanchnic haemodynamics

Indexed keywords

METFORMIN; ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET THERAPY; DOPPLER ECHOGRAPHY; FEMALE; HEMODYNAMICS; HEPATOMEGALY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER BIOPSY; LIVER WEIGHT; MALE; NONALCOHOLIC FATTY LIVER; PATIENT MONITORING; PILOT STUDY; PORTAL VEIN BLOOD FLOW; SPLANCHNIC BLOOD FLOW; ULTRASOUND TRANSDUCER; VASCULAR RESISTANCE; BLOOD; CLINICAL TRIAL; DIET; DOPPLER FLOWMETRY; ECHOGRAPHY; FATTY LIVER; LIVER; LIVER CIRCULATION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PORTAL VEIN; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; BLOOD FLOW VELOCITY; DIET; FATTY LIVER; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPOGLYCEMIC AGENTS; LIVER; LIVER CIRCULATION; MALE; METFORMIN; MIDDLE AGED; PILOT PROJECTS; PORTAL VEIN; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 7244254380     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2004.01.023     Document Type: Article

References (30)

1. Younossi ZM, Diehl AM, Ong PJ. Nonalcoholic fatty liver disease: An agenda for clinical research. Hepatology 2002;35:746-52.
2. Fong DG, Nehra V, Lindor K, Buchman AL. Metabolic and nutritional considerations in non alcoholic fatty liver. Hepatology 2000;32:458-62.
3. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001;121: 710-23.
4. Loguercio C, De Girolamo V, de Sio I, Tucillo C, Ascione A, Baldi F, et al. Non-alcoholic fatty liver disease in an area of southern Italy: Main clinical, histological, and pathophysiological aspects. J Hepatol 2001;35:568-74.
5. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
6. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes 2001;50:1844-50.
7. Marchesini G, Brizi M, Morselli Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease to insulin resistance. Am J Med 1999;107:450-5.
8. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116: 1413-9.
9. Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in hepatic parenchymal microcirculation. Transplantation 1999;68:780-4.
10. Marhesini G, Brizi M, Bianchi G, Tomasetti S, Zoli M, Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet 2001;358: 893-4.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
12. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
13. Joseph AE, Saverymuttu SH. Ultrasound in the assessment of diffuse parenchymal liver disease. Clin Radiol 1991;44:219-21.
14. Taylor KJ, Riely CA, Hammers L, Flax S, Weltin G, Garcia Tsao G, et al. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: Importance of fat. Radiology 1986;160:65-71.
15. Zoli M, Pisi P, Marchesini G, Bianchi G, Turci GA, Pisi E. A rapid method for the in vivo measurement of liver volume. Liver 1989;9:159-63.
16. Harbin WP, Robert NJ, Ferrucci JT. Diagnosis of cirrhosis based on regional changes in hepatic morphology. Radiology 1980;135:273-83.
17. Sabbà C, Merkel C, Zoli M, Ferraioli G, Gaiani S, Sacerdoti D, et al. Interobserver and interequipment variability of echo Doppler examination of the portal vein: Effect of a cooperative training program. Hepatology 1995;21:428-33.
18. Moriyasu F, Nishida O, Ban N, Nakamura T, Sakai M, Miyake T, et al. "Congestion index" of the portal vein. Am J Roentgenol 1986;146:735-9.
19. Sacerdoti D, Gaiani S, Buonamico P, Merkel C, Zoli M, Bolondi L, et al. Interobserver and interequipment variability of hepatic. J Hepatol 1997;27:986-92.
20. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 2000;6:998-1003.
21. SAS Institute Inc. SAS user's guide: Statistics, version 5. Cary, NC: SAS Institute Inc.; 1985. p. 795-800.
22. Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC. Fatty infiltration of the liver: Ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984;3:9-14.
23. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-50.
24. Mathiesen UL, Franzen LE, Aselius H, Resjö M, Jacobsson L, Foberg U, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002;34:516-22.
25. Tsushima Y, Endo K. Spleen enlargement in patients with nonalcoholic fatty liver: Correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci 2000;45:196-200.
26. Seifalian AM, El-Desoky A, Davidson BR. Hepatic indocyanine green uptake and excretion in a rabbit model of steatosis. Eur Surg Res 2001;33:193-201.
27. Hamato N, Moriyasu F, Someda H, Nishikawa K, Chiba T, Okuma M. Clinical application of hepatic venous hemodynamics by Doppler ultrasonography in chronic liver disease. Ultrasound Med Biol 1997;23:829-35.
28. Dietrich CF, Lee JH, Gottschalk R, Herrmann G, Sarrazin C, Caspary WF, et al. Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. Am J Roentgenol 1998;171:437-43.
29. Seifalian AM, Chidambaram V, Rolles K, Davidson BR. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg 1998;4:71-7.
30. Kasahara A, Hayashi N, Sasaki Y, Katayama K, Kono M, Yashima T, et al. Hepatic circulation and hepatic oxygen consumption in alcoholic and nonalcoholic fatty liver. Am J Gastroenterol 1988;83: 846-9.